semaglutide side effects hair loss female Does Cause Loss? An Answer To The Research Master Hair Loss Management: What

Presented for research literature review only Seirafianpour F et al

Patients who achieve goal weight and wish to reduce costs without stopping treatment entirely sometimes transition to lower maintenance doses (1.0mg1.4mg weekly) after 69 months at therapeutic levels

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), notably the long-acting agonist semaglutide, exhibit significant metabolic efficacy and pronounced neuroprotective effects across a broad spectrum of preclinical models

In December 2025, the FDA also approved an oral tablet version of Wegovy, making semaglutide the first GLP-1 weight loss medication available as both an injection and a pill